
Work on vaccines will have to continue on parallel tracks - one to tackle the SARS-CoV-2 virus with first generation vaccines and the other to prepare for possible mutations and new variants - say experts as they map the future course of the infection.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cgPmSn
via
IFTTT
0 comments:
Post a Comment